VetnCare Announces Matthew J. Kirchner as Chief Executive Officer; Founder Dr. Andrew Moffatt to Continue Leadership Role as Chief Medical Officer

VetnCare has more than doubled in size since 2022 when it began its partnership with Great Point Partners

OAKLAND, Calif.--(BUSINESS WIRE)--VetnCare (or “the Company”), a growing community of veterinary hospitals based in Northern California, has appointed Matthew J. Kirchner as Chief Executive Officer. As part of the transition, Founder Dr. Andrew Moffatt will assume the role of Chief Medical Officer, where he will support the continuing expansion and evolution of the business.

Mr. Kirchner is a seasoned executive with more than a decade of leadership in health care and education businesses. He has extensive experience across health care services, medical devices, biotech, and pharmaceuticals with an emphasis on organic business growth and optimized operations. He will also be joining VetnCare’s board of directors.

“Having spent the majority of my career in human healthcare, I’m excited to bring my business expertise and personal passion for animals to such an important field. Pet care will continue to be a top priority for so many, and we are dedicated to leading with comprehensive and innovative care,” said VetnCare CEO Matt Kirchner. “Dr. Moffatt’s leadership over more than a decade has positioned VetnCare for continued growth and excellence.”

“Having spent time with Matt, it is clear that we have a shared vision for our Community’s future and strong value alignment. I’m thrilled to have him lead our organization forward, and equally excited to embrace the Chief Medical Officer role, on our growing leadership team,” VetnCare Founder Dr. Andrew Moffatt said. “Twelve years ago, I set out to reimagine the local veterinary hospital by establishing a community of veterinary professionals committed to advancing the quality of their clinical care. Today, we are more committed than ever to this purpose - elevating care for pets and the people who care for them.”

At the end of 2022, Great Point Partners (“GPP,” or “the Firm”), a Greenwich-based private investment firm focused exclusively on the health care industry, partnered with VetnCare to support its planned expansion trajectory. Over the past two years, VetnCare has more than doubled their size as part of its ongoing expansion.

“Based on Matt’s track record and experience across his prior roles, I am thrilled to welcome him aboard as VetnCare’s leader and support the bright future ahead,” said Eddie Hjerpe, Senior Vice President with GPP. “Andrew’s vision and strategy has allowed VetnCare to achieve its current success, and we look forward to continuing to work with the team to build a leading veterinary hospital community.”

About VetnCare

VetnCare is a community of veterinary hospitals in Northern California that focuses on providing exceptional clinical care to pets throughout their lives. By investing in the development of our local leaders and clinical teams, pets and pet parents can access wellness and advanced veterinary services including surgery, imaging, urgent care as well as numerous specialties (oncology, ophthalmology, dermatology, orthopedic surgery and exotics).

About Great Point Partners

Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new minority and majority private equity investments from GPP IV. Great Point manages approximately $1.5B of capital (including committed and uncalled capital) in its private funds and public life sciences equity strategy (BioMedical Value Fund). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 100 growing health care companies. The private equity funds invest across all sectors of the health care industry with a particular emphasis on biopharmaceutical services and supplies, alternate site care, medical device contract manufacturing and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.